Literature DB >> 4227822

The effect of aurovertin on a soluble mitochondrial adenosine triphosphatase.

A M Roberton, R B Beechey, C T Holloway, I G Knight.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4227822      PMCID： PMC1271265          DOI： 10.1042/bj1040054c

Source DB:  PubMed          Journal:  Biochem J        ISSN： 0264-6021            Impact factor:   3.857


× No keyword cloud information.
  6 in total

1.  ANTIBIOTIC STUDIES. II. INHIBITION OF PHOSPHORYL TRANSFER IN MITOCHONDRIA BY OLIGOMYCIN AND AUROVERTIN.

Authors:  H A LARDY; J L CONNELLY; D JOHNSON
Journal:  Biochemistry       Date:  1964-12       Impact factor: 3.162

2.  The isolation and purification of a bovine-plasma protein which is a substrate for the coagulant fraction of Russell's-viper venom.

Authors:  M P ESNOUF; W J WILLIAMS
Journal:  Biochem J       Date:  1962-07       Impact factor: 3.857

3.  Partial resolution of the enzymes catalyzing oxidative phosphorylation. I. Purification and properties of soluble dinitrophenol-stimulated adenosine triphosphatase.

Authors:  M E PULLMAN; H S PENEFSKY; A DATTA; E RACKER
Journal:  J Biol Chem       Date:  1960-11       Impact factor: 5.157

4.  Partial resolution of the enzymes catalyzing oxidative phosphorylation. II. Participation of a soluble adenosine tolphosphatase in oxidative phosphorylation.

Authors:  H S PENEFSKY; M E PULLMAN; A DATTA; E RACKER
Journal:  J Biol Chem       Date:  1960-11       Impact factor: 5.157

5.  Partial resolution of the enzymes catalyzing oxidative phosphorylation. 8. Properties of a factor conferring oligomycin sensitivity on mitochondrial adenosine triphosphatase.

Authors:  Y Kagawa; E Racker
Journal:  J Biol Chem       Date:  1966-05-25       Impact factor: 5.157

6.  Partial resolution of the enzymes catalyzing oxidative phosphorylation. IX. Reconstruction of oligomycin-sensitive adenosine triphosphatase.

Authors:  Y Kagawa; E Racker
Journal:  J Biol Chem       Date:  1966-05-25       Impact factor: 5.157
  6 in total
  8 in total

1.  A simple and rapid method for the preparation of adenosine triphosphatase from submitochondrial particles.

Authors:  R B Beechey; S A Hubbard; P E Linnett; A D Mitchell; E A Munn
Journal:  Biochem J       Date:  1975-06       Impact factor: 3.857

2.  Mitochondrial adenosine triphosphatase of the fission yeast, Schizosaccharomyces pombe 972h-. Changes in activity and inhibitor-sensitivity in response to catabolite repression.

Authors:  D Lloyd; S W Edwards
Journal:  Biochem J       Date:  1976-11-15       Impact factor: 3.857

Review 3.  Recent developments on structural and functional aspects of the F1 sector of H+-linked ATPases.

Authors:  P V Vignais; M Satre
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

4.  Interaction of Escherichia coli adenosine triphosphatase with aurovertin and citreoviridin: inhibition and fluorescence studies.

Authors:  M Satre; M Bof; P V Vignais
Journal:  J Bacteriol       Date:  1980-06       Impact factor: 3.490

5.  Mitochondrial adenosine triphosphatase of the fission yeast Schizosaccharomyces pombe 972h-. Changes in inhibitor sensitivities during the cell cycle indicate similarities and differences in binding sites.

Authors:  D Lloyd; S W Edwards
Journal:  Biochem J       Date:  1977-03-15       Impact factor: 3.857

6.  Citreoviridin, a specific inhibitor of the mitochondiral adenosine triphosphatase.

Authors:  P E Linnett; A D Mitchell; M D Osselton; L J Mulheirn; R B Beechey
Journal:  Biochem J       Date:  1978-03-15       Impact factor: 3.857

7.  Isolation of Escherichia coli mutants with an adenosine triphosphatase insensitive to aurovertin.

Authors:  M Satre; G Klein; P V Vignais
Journal:  J Bacteriol       Date:  1978-04       Impact factor: 3.490

8.  Mechanistic basis for differential inhibition of the F1Fo-ATPase by aurovertin.

Authors:  Kathryn M Johnson; Lara Swenson; Anthony W Opipari; Rolf Reuter; Nawid Zarrabi; Carol A Fierke; Michael Börsch; Gary D Glick
Journal:  Biopolymers       Date:  2009-10       Impact factor: 2.505
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.